Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지
DOI QR코드

DOI QR Code

Single and Multiple Valve Surgery in Native Valve Infective Endocarditis

  • Kim, Tae Sik (Department of Thoracic and Cardiovascular Surgery, Sejong General Hospital) ;
  • Na, Chan-Young (Department of Thoracic and Cardiovascular Surgery, Keimyung University Dongsan Medical Center) ;
  • Oh, Sam Sae (Department of Thoracic and Cardiovascular Surgery, Sejong General Hospital) ;
  • Kim, Jae Hyun (Department of Thoracic and Cardiovascular Surgery, Sejong General Hospital) ;
  • Yie, Gil Soo (Department of Thoracic and Cardiovascular Surgery, Sejong General Hospital) ;
  • Han, Jung Wook (Department of Thoracic and Cardiovascular Surgery, Sejong General Hospital) ;
  • Chae, Min Cheol (Department of Thoracic and Cardiovascular Surgery, Keimyung University Dongsan Medical Center)
  • Received : 2012.11.16
  • Accepted : 2013.03.07
  • Published : 2013.08.05
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Surgical treatment of infective endocarditis (IE) remains a challenge, especially in cases of multiple valve surgery. We evaluated the clinical outcomes of native valve IE and compared the outcomes of single valve surgery with those of multiple valve surgery. Materials and Methods: From 1997 to 2011, 90 patients underwent surgery for native valve IE; 67 patients with single valve surgery (single valve group) and 23 patients with multiple valve surgery (multiple valve group). The mean follow-up duration was $73.1{\pm}47.4$ months. Results: The surgical mortality in the total cohort was 4.4%. The overall survival (p=0.913) and valve-related event-free survival (p=0.204) did not differ between the two groups. The independent predictor of postoperative complications was New York Heart Association class (p=0.001). Multiple valve surgery was not a significant predictor of surgical mortality (p=0.225) or late mortality (p=0.936). Uncontrolled infection, urgent or emergency surgery, and postoperative complications were identified as independent predictors of valve-related morbidity, excluding multiple valve surgery (p=0.072). Conclusion: In native valve IE, multiple valve surgery as a factor was not an independent predictor of mortality and morbidity. The number of surgically corrected valves in native IE seems to be unrelated to perioperative and long-term outcomes.

Keywords

References

  1. Hoen B, Alla F, Selton-Suty C, et al. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 2002;288:75-81. https://doi.org/10.1001/jama.288.1.75
  2. Selton-Suty C, Doco-Lecompte T, Bernard Y, et al. Clinical and microbiologic features of multivalvular endocarditis. Curr Infect Dis Rep 2010;12:237-43. https://doi.org/10.1007/s11908-010-0112-5
  3. Mueller XM, Tevaearai HT, Stumpe F, et al. Multivalvular surgery for infective endocarditis. Cardiovasc Surg 1999;7: 402-8. https://doi.org/10.1016/S0967-2109(98)00152-5
  4. Gillinov AM, Diaz R, Blackstone EH, et al. Double valve endocarditis. Ann Thorac Surg 2001;71:1874-9. https://doi.org/10.1016/S0003-4975(01)02603-0
  5. Mihaljevic T, Byrne JG, Cohn LH, Aranki SF. Long-term results of multivalve surgery for infective multivalve endocarditis. Eur J Cardiothorac Surg 2001;20:842-6. https://doi.org/10.1016/S1010-7940(01)00865-X
  6. Siniawski H, Grauhan O, Hofmann M, et al. Aortic root abscess and secondary infective mitral valve disease: results of surgical endocarditis treatment. Eur J Cardiothorac Surg 2005; 27:434-40. https://doi.org/10.1016/j.ejcts.2004.12.001
  7. Musci M, Siniawski H, Pasic M, et al. Surgical treatment of right-sided active infective endocarditis with or without involvement of the left heart: 20-year single center experience. Eur J Cardiothorac Surg 2007;32:118-25. https://doi.org/10.1016/j.ejcts.2007.02.034
  8. Musci M, Siniawski H, Pasic M, et al. Surgical therapy in patients with active infective endocarditis: seven-year single centre experience in a subgroup of 255 patients treated with the Shelhigh stentless bioprosthesis. Eur J Cardiothorac Surg 2008;34:410-7. https://doi.org/10.1016/j.ejcts.2008.05.007
  9. Sheikh AM, Elhenawy AM, Maganti M, Armstrong S, David TE, Feindel CM. Outcomes of double valve surgery for active infective endocarditis. J Thorac Cardiovasc Surg 2009; 138:69-75. https://doi.org/10.1016/j.jtcvs.2008.11.049
  10. Yao F, Han L, Xu ZY, et al. Surgical treatment of multivalvular endocarditis: twenty-one-year single center experience. J Thorac Cardiovasc Surg 2009;137:1475-80. https://doi.org/10.1016/j.jtcvs.2008.11.046
  11. Ota T, Gleason TG, Salizzoni S, Wei LM, Toyoda Y, Bermudez C. Midterm surgical outcomes of noncomplicated active native multivalve endocarditis: single-center experience. Ann Thorac Surg 2011;91:1414-9. https://doi.org/10.1016/j.athoracsur.2010.12.004
  12. Habib G, Thuny F, Avierinos JF. Prosthetic valve endocarditis: current approach and therapeutic options. Prog Cardiovasc Dis 2008;50:274-81. https://doi.org/10.1016/j.pcad.2007.10.007
  13. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000;30:633-8. https://doi.org/10.1086/313753
  14. Akins CW, Miller DC, Turina MI, et al. Guidelines for reporting mortality and morbidity after cardiac valve interventions. Eur J Cardiothorac Surg 2008;33:523-8. https://doi.org/10.1016/j.ejcts.2007.12.055
  15. Delahaye F, Alla F, Beguinot I, et al. In-hospital mortality of infective endocarditis: prognostic factors and evolution over an 8-year period. Scand J Infect Dis 2007;39:849-57. https://doi.org/10.1080/00365540701393088
  16. Kim N, Lazar JM, Cunha BA, Liao W, Minnaganti V. Multi-valvular endocarditis. Clin Microbiol Infect 2000;6: 207-12. https://doi.org/10.1046/j.1469-0691.2000.00065.x